FC-reduced anti-TIGIT antibodies
Search documents
Compugen(CGEN) - 2025 Q3 - Earnings Call Transcript
2025-11-10 14:32
Compugen (NasdaqCM:CGEN) Q3 2025 Earnings Call November 10, 2025 08:30 AM ET Company ParticipantsEran Ophir - President and CEODavid Silberman - CFOYvonne Naughton - VP and Head of Investor Relations and Corporate CommunicationsMichelle Mahle - CMOConference Call ParticipantsStephen Willey - AnalystDaina Graybosch - Senior Research AnalystSwayampakula Ramakanth - AnalystAsthika Goonewardene - AnalystLeland Gershell - Senior AnalystOperatorLadies and gentlemen, thank you for joining us today. Welcome to the ...
Compugen(CGEN) - 2025 Q3 - Earnings Call Transcript
2025-11-10 14:32
Compugen (NasdaqCM:CGEN) Q3 2025 Earnings Call November 10, 2025 08:30 AM ET Company ParticipantsEran Ophir - President and CEODavid Silberman - CFOYvonne Naughton - VP and Head of Investor Relations and Corporate CommunicationsMichelle Mahle - CMOConference Call ParticipantsStephen Willey - AnalystDaina Graybosch - Senior Research AnalystSwayampakula Ramakanth - AnalystAsthika Goonewardene - AnalystLeland Gershell - Senior AnalystOperatorLadies and gentlemen, thank you for joining us today. Welcome to the ...